For a healthier tomorrow

“Renoir RSV Vaccine”

A Phase 3 Study to ” Phase 3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults

"Vanir RSV-MVA-004"

A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN®-RSV Vaccine in Adults ≥60 Years of Age

Phase 3 study to investigate the efficacy and safety of the oral factor XIa (FXIa) inhibitor

asundexian (BAY 2433334) compared with apixaban in participants with atrial fibrillation at risk for stroke